기자가 쓴 기사 더보기
The following is a general assumption.
Health care systems in which specialist (i.e. MD's in specific practice areas) and hospital care are accessible ONLY after obtaining a referral from general practitioners (GP) have LOWER total health care costs.
In a recent seminar, Professor Kim Yang-kyun of Kyunghee University said the government should introduce a two-way referral system in health care delivery, to bring forth more efficiency.
The proposed two-way referral system in health care delivery is a working relationship between a primary health care provider (or facility) and a high-tier hospital (or facility) at the time of transfer and discharge of a patient.
Individuals should be limited to certain medical facilities (i.e. tier-wise) which accept the particular type of medical insurance they carry, according to Professor Kim.
Kim said that patient visits to medical facilities outside the insurance program's "network" are usually not covered, and the patient must bear more of the cost.
He also commented that hospitals should negotiate with insurance programs to set reimbursement rates (some rates for government insurance programs are set by law).
In Japan, medical services are provided either through regional/national public hospitals or through private hospitals/clinics. Patients have universal access to any facilities, though hospitals tend to charge higher for those without a referral.
Public health insurance covers most citizens/residents and pays 70% or more cost for each care, and each prescribed drug. Patients are responsible for the remainder (upper limits apply). The monthly insurance premium is 0-50,000 Japanese Yen per household (scaled to annual income).
Supplementary private health insurance is available only to cover the co-payments or non-covered costs, and usually makes a fixed payment per days in hospital or per surgery performed, rather than per actual expenditure.
In 2005, Japan spent 8.2% of GDP on health care, or US$2,908 per capita. Of that, approximately 83% was government expenditure.
<기사원문>
관련기사에 링크되어 있습니다.
| 인기기사 | 더보기 + |
| 1 | 근감소증 신약개발 선두주자 바이오피티스, 근육량 넘어 ‘기능 개선’ 초점 |
| 2 | 글로벌 상위 20개 제약사,지난해 수익 '개선'-생산성 '근본적 위협' |
| 3 | 비씨월드제약, 세 번째 ODT 시리즈 고혈압 치료제 ‘암바로오디정’ 품목 허가 |
| 4 | "근육 줄어드는 근감소증도 질병, 조기진단과 식이 운동요법 병행돼야" |
| 5 | HK이노엔,케이캡 미국 3상서 PPI 우월성 확인…GERD 치료 패러다임 전환 신호 |
| 6 | 삼익제약,2030년 매출 1300억원-영업익 110억원 도전 |
| 7 | 셀트리온, 1Q 1조1450억 36%↑-영업익 115.5%↑..1분기 최대 실적 |
| 8 | [진단과치료] 근감소증(Sarcopenia)의 진단과 치료전략 |
| 9 | 지씨셀, 일본 후생노동성 ‘특정세포가공물 제조인증(CPC)’ 최종 획득 |
| 10 | 삼성바이오로직스 노사 1대1 면담 취소…8일 노사정 대화로 넘어간 협상 |
| 인터뷰 | 더보기 + |
| PEOPLE | 더보기 + |
| 컬쳐/클래시그널 | 더보기 + |
The following is a general assumption.
Health care systems in which specialist (i.e. MD's in specific practice areas) and hospital care are accessible ONLY after obtaining a referral from general practitioners (GP) have LOWER total health care costs.
In a recent seminar, Professor Kim Yang-kyun of Kyunghee University said the government should introduce a two-way referral system in health care delivery, to bring forth more efficiency.
The proposed two-way referral system in health care delivery is a working relationship between a primary health care provider (or facility) and a high-tier hospital (or facility) at the time of transfer and discharge of a patient.
Individuals should be limited to certain medical facilities (i.e. tier-wise) which accept the particular type of medical insurance they carry, according to Professor Kim.
Kim said that patient visits to medical facilities outside the insurance program's "network" are usually not covered, and the patient must bear more of the cost.
He also commented that hospitals should negotiate with insurance programs to set reimbursement rates (some rates for government insurance programs are set by law).
In Japan, medical services are provided either through regional/national public hospitals or through private hospitals/clinics. Patients have universal access to any facilities, though hospitals tend to charge higher for those without a referral.
Public health insurance covers most citizens/residents and pays 70% or more cost for each care, and each prescribed drug. Patients are responsible for the remainder (upper limits apply). The monthly insurance premium is 0-50,000 Japanese Yen per household (scaled to annual income).
Supplementary private health insurance is available only to cover the co-payments or non-covered costs, and usually makes a fixed payment per days in hospital or per surgery performed, rather than per actual expenditure.
In 2005, Japan spent 8.2% of GDP on health care, or US$2,908 per capita. Of that, approximately 83% was government expenditure.
<기사원문>
관련기사에 링크되어 있습니다.